The disease burden moves to the ageing brain, and control of neurodegeneration becomes the century's central health inequality
The dominant burden of disease shifts decisively from mortality to dependency, and partial control of that dependency arrives — not as a single cure but…
Claude · 2082–2182 · likely
Prior state
At the interval's start, life expectancy in high-capacity systems sits in the mid-eighties to low nineties, dementia prevalence is rising as a direct consequence of that success, and care is already the largest employment sector in the most aged societies. Detection has improved faster than treatment.
Material change
The dominant burden of disease shifts decisively from mortality to dependency, and partial control of that dependency arrives — not as a single cure but as a therapy stack: cheap biomarker-based detection decades before symptoms, multi-target maintenance regimes that delay onset by years, and later partial regenerative and replacement approaches. Because delay without cure converts a fatal illness into a long and expensive one, the stack's distribution rather than its existence becomes the decisive variable. Within reach of the stack, the dependent tail compresses; outside it, the tail lengthens as longevity rises without it.
Why now
The compositional shift runs throughout the century because it is driven by competing risks rather than by any single event. The inflection comes at mid-century, when the therapy stack's cost falls below the cost of institutional care for the median aged household in middle-income systems — the point at which paying for it becomes fiscally rational rather than merely humane, and the point at which failing to fund it becomes a visible political choice.
Mechanism and resistance
The resistance is fiscal rather than scientific. The therapies are chronic, lifelong, and expensive, and the payers are ageing societies with contracting tax bases undergoing the fiscal reconstruction of DEV-10. There is also resistance from within the care sector itself, whose scale and employment depend on the dependency the stack reduces, and from the reality that adherence over decades in cognitively impaired populations is a delivery problem no molecule solves.
Consequences
The largest cross-national health inequality of the century is not infant survival — that gap closes — but the length of the dependent tail at the end of life. Systems that fund the stack see healthy life expectancy converge toward total life expectancy; systems that do not see a rising share of national income and, more importantly, of family and non-family care labour absorbed by long dependency. Eligibility rules for the stack become the most contested distributive question in aged polities, more salient than pensions, because the good in question is the character of one's own ending. Within countries the inequality is generational as much as economic: the cohorts that reach old age before the stack becomes affordable carry the burden for those that follow.
End state
In high-capacity systems dementia is a managed chronic condition with a dependent tail measured in a small number of years. Elsewhere it is the leading cause of household impoverishment and the largest single claim on the time of working-age relatives, in societies that by then have very few of them.
Observable test
the gap between total life expectancy and healthy life expectancy at older ages narrows markedly in some health systems while widening in others over the same decades, with the share of health expenditure attributable to neurodegenerative and frailty care diverging correspondingly.
Disconfirming sign
no therapy stack materially delays onset, and dependent-tail duration lengthens roughly uniformly across all systems as longevity rises, making this a story about universal burden rather than divergence.